Large-scale testing (Phase 3)Study completedNCT04516967
What this trial is testing
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 75